Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umberto Vitolo

Showing results (1-10 of 212) with videos related to

Pageof 22
Sort By:
Hemasphere|March 21, 2022
Large B-cell lymphomasUmberto Vitolo
Blood|October 19, 2023
A new frontier for R-CHOP: is two better than one?Umberto Vitolo, Annalisa Chiappella
The Lancet. Oncology|August 21, 2018
Brentuximab vedotin-based salvage treatment in Hodgkin's lymphomaUmberto Vitolo, Annalisa Chiappella
The Lancet. Oncology|January 25, 2022
Frontline chemotherapy-free induction for mantle cell lymphomaUmberto Vitolo, Mattia Novo
The Lancet. Haematology|April 3, 2019
Monoclonal antibody-drug conjugates in B-cell lymphomasAnnalisa Chiappella, Umberto Vitolo
Blood|February 4, 2021
Bcl-2 inhibition in DLBCL: "the times they are a-changing"?Umberto Vitolo, Mattia Novo
Expert Review of Hematology|September 24, 2011
Highlights in lymphoma: overview of the 11th International Conference on Malignant LymphomaAnnalisa Chiappella, Umberto Vitolo
The Lancet. Haematology|November 4, 2018
Histological transformation and secondary malignancies in follicular lymphomaUmberto Vitolo, Annalisa Chiappella
Advances in Hematology|July 14, 2012
Lenalidomide in diffuse large B-cell lymphomasAnnalisa Chiappella, Umberto Vitolo
The Lancet. Oncology|December 26, 2017
Salvage regimens for Hodgkin's lymphoma in the brentuximab vedotin eraUmberto Vitolo, Annalisa Chiappella
Pageof 22

Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
Hemasphere|March 21, 2022
Large B-cell lymphomasUmberto Vitolo
Blood|October 19, 2023
A new frontier for R-CHOP: is two better than one?Umberto Vitolo, Annalisa Chiappella
The Lancet. Oncology|August 21, 2018
Brentuximab vedotin-based salvage treatment in Hodgkin's lymphomaUmberto Vitolo, Annalisa Chiappella
The Lancet. Oncology|January 25, 2022
Frontline chemotherapy-free induction for mantle cell lymphomaUmberto Vitolo, Mattia Novo
The Lancet. Haematology|April 3, 2019
Monoclonal antibody-drug conjugates in B-cell lymphomasAnnalisa Chiappella, Umberto Vitolo
Blood|February 4, 2021
Bcl-2 inhibition in DLBCL: "the times they are a-changing"?Umberto Vitolo, Mattia Novo
Expert Review of Hematology|September 24, 2011
Highlights in lymphoma: overview of the 11th International Conference on Malignant LymphomaAnnalisa Chiappella, Umberto Vitolo
The Lancet. Haematology|November 4, 2018
Histological transformation and secondary malignancies in follicular lymphomaUmberto Vitolo, Annalisa Chiappella
Advances in Hematology|July 14, 2012
Lenalidomide in diffuse large B-cell lymphomasAnnalisa Chiappella, Umberto Vitolo
The Lancet. Oncology|December 26, 2017
Salvage regimens for Hodgkin's lymphoma in the brentuximab vedotin eraUmberto Vitolo, Annalisa Chiappella
Pageof 22